The fervor surrounding the European Union’s implementation of its General Data Protection Regulation (GDPR) legislation is feeding an increased expectation to respect the privacy rights of the individual. Other initiatives—right here in the United States—are taking hold. On June 28, California Governor Jerry Brown signed the California Consumer Privacy Act (CCPA) of 2018, blazing the trail for heightened personal data control and protection in the U.S.
DMD’s core values represent our ardent dedication to clients and partners. Two of those values in particular, industry leadership and integrity, have been recognized once again. Our patent-pending Audience Identity ManagerSM (AIM) technology recently earned BPA Worldwide certification for its conformance to the BPA Worldwide rules for audience qualification and IAB Data Best Practices.
We already maintain the first and only physician email database fully audited and classified as a verified source by BPA Worldwide. Now, after a thorough assessment, our AIM platform joins email in this highly-regarded “place at the podium.”
These days, nearly everyone who works with data is concerned about the General Data Protection Regulation (GDPR). Fair enough. Every company bigger than a peanut stand needs to give GDPR some thought. Its guidelines are far-reaching, and penalties for non-compliance are stiff.
Still, GDPR is hardly the end of the world for healthcare marketers, particularly those who have invested in compliant data partners. Though GDPR doesn’t take effect until May 25, DMD has been handling healthcare professional data responsibly for years.
Data-driven marketing was a powerful tool for pharma marketers in 2017. At the beginning of the year, audience identity management technology reported the online behavior of opted-in HCP visitors to your pharma brand sites. By year end, this capability had been extended across a digital ecosystem of more than 300 medical websites.
In the creation and maintenance of an email database, relationships reign supreme. For healthcare, the key players are medical publishers and AMA database licensees:
To Our Friends and Colleagues,
Thank you for giving us so much—our families, rights, freedom, economy, and health. Even with all of the many compromises we make and endure, we have so much to be thankful for this Thanksgiving.
Our lives started with our mothers who gave us life and sustenance before we came into this world. This Thanksgiving, I would like to give thanks to my mother, who made sure I had two new Kleenex tissues everyday, folded into quarters and then tucked into my pants pocket when I went off to kindergarten. She would inspect me up and down before deeming me fit to walk into PS 222 in Brooklyn.
Co-hosts of the Hospital Marketing National Podcast, Scott Ehrlich, president and chief operating officer at DTC Perspectives*, and Patrick Bender, DTC’s manager of hospital sales and business development, recently sat down with DMD CCO Chris Lee to discuss DMD’s leadership in healthcare digital marketing.
Industry conferences are a rich opportunity for companies to report on trends, share their best practices, and introduce new products to their peers and colleagues. DMD has had the pleasure of presenting at some of these conferences as a pioneer in audience identity technology.
In this fifth and final installment of our summer wrap-up, I invite you to take a look at three topics that some of our DMD thought leaders spoke about over the past year.
With pharma reps being increasingly squeezed out of in-person meetings due to lack of time and resources, connecting with HCPs via email is a crucial step forward. Digital marketing is one way to ensure you get through the “virtual door” and provide pertinent information in a timely, succinct manner.
Fraud is not a new concept. Snake oil, advertised to cure everything from arthritis to bursitis in the days of yore, was widely utilized as a way to swindle one’s hard-earned money.
Today, fraud takes a different form. The virtual world has allowed for fraudulent activity to be off-the-charts effective. Unfortunately, the pharmaceutical industry has a large target on its back in this regard.